Streetbeat News

CANSF

Willow Biosciences Inc

https://www.willowbio.com/

CEO

Trevor Peters

Industry

Dimension Stone Mining and Quarrying

Open

0.06

Mkt cap

8.6M

Volume

27K

High

0.06

P/E Ratio

-1.49

52-wk high

0.10

Low

0.06

Div yield

N/A

52-wk low

0.05

Willow Biosciences Inc. has announced a partnership with a global ingredient manufacturer to develop, scale, and commercialize a high-value ingredient from its portfolio.

Portfolio Pulse from

November 07, 2024 | 12:15 pm

Willow Biosciences Inc. (OTCQB:CANSF) reported record Q2 2024 revenue, driven by a strategic partnership with Laurus Labs. The company saw a 660% year-over-year revenue increase and reduced costs, despite a net loss of $1.7 million due to R&D investments. Willow expects fiscal year 2024 revenues to exceed $4 million, a 350% increase over 2023.

Portfolio Pulse from Jelena Martinovic

August 12, 2024 | 7:30 pm

Willow Biosciences Inc. (OTCQB:CANSF) reported a 60% revenue increase in 2023, driven by its synthetic biology techniques and the launch of its BioOxi bio-oxidation platform technology. The company engaged in multiple partnerships, including with Kalsec and an undisclosed Nasdaq-listed biopharmaceutical company, and underwent corporate restructuring. For 2024, Willow Biosciences aims to achieve over 100% increase in R&D revenues, sign commercial agreements, and advance its core technology platform. The article also mentions cannabis stocks, including Green Thumb Industries Inc. (OTCQX:GTBIF), Trulieve Cannabis Corp. (OTCQX:TCNNF), and Village Farms International, Inc. (NASDAQ:VFF), as having potential for growth.

Portfolio Pulse from Jelena Martinovic

January 10, 2024 | 7:38 pm

Willow Biosciences Inc. (OTCQB:CANSF) reported strong financial results for Q3 2023, with record revenue of $0.7 million and year-to-date revenue of $1.1 million. The company, specializing in precision fermentation for health and wellness, food and beverage, and personal care markets, has made significant strides in business expansion and operational efficiency. Key achievements include a reduction in cash burn, a successful insider-led convertible debenture financing, and progress in various R&D programs. Willow also settled patent litigation with Aurora Cannabis Inc. (NASDAQ:ACB). Shares of CANSF rose 8.13% to $0.0556.

Portfolio Pulse from Joana Scopel

November 15, 2023 | 9:45 pm

Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) and Willow Biosciences Inc. (OTCQB:CANSF) (TSX:WLLW) have resolved their ongoing patent litigation through a confidential settlement. Aurora had accused Willow of infringing on its exclusive rights to patents co-owned by the University of Saskatchewan and the National Research Council. The patents in question were related to the biosynthetic process for synthesizing cannabinoids. Aurora's shares traded 0.8728% higher following the announcement.

Portfolio Pulse from Jelena Martinovic

October 24, 2023 | 2:59 pm

The article lists the cannabis stocks that gained and lost on August 25, 2023. Notable gainers include Clever Leaves Holdings (NASDAQ:CLVR) and Skye Bioscience (OTC:SKYE), while notable losers include Australis Capital (OTC:AUSAF) and Red White & Bloom Brands (OTC:RWBYF).

Portfolio Pulse from Benzinga Insights

August 25, 2023 | 9:30 pm

The article lists the marijuana stocks that gained and lost on August 22, 2023. The biggest gainers were Red White & Bloom Brands (OTC:RWBYF), Radient Technologies (OTC:RDDTF), and Heritage Cannabis Holding (OTC:HERTF). The biggest losers were EVIO (OTC:EVIO), Choom Holdings (OTC:CHOOF), and Tetra Bio Pharma (OTC:TBPMF).

Portfolio Pulse from Benzinga Insights

August 22, 2023 | 9:30 pm

The cannabis sector experienced mixed performance on August 21, 2023, with several stocks seeing significant gains, while others suffered losses. Notable gainers include Radient Technologies (OTC:RDDTF), Trees (OTC:CANN), and 1933 Industries (OTC:TGIFF), while Red White & Bloom Brands (OTC:RWBYF), CBD Of Denver (OTC:CBDD), and Tetra Bio Pharma (OTC:TBPMF) were among the biggest losers.

Portfolio Pulse from Benzinga Insights

August 21, 2023 | 9:30 pm

On August 18, 2023, several cannabis stocks experienced significant price movements. Notable gainers include Australis Capital (OTC:AUSAF), Target Group (OTC:CBDY), and 1606 (OTC:CBDW), with shares closing up 900.00%, 63.64%, and 44.68% respectively. On the other hand, Panacea Life Sciences (OTC:PLSH), MGC Pharmaceuticals (OTC:MGCLF), and 1933 Industries (OTC:TGIFF) were among the biggest losers, with shares closing down 24.00%, 23.33%, and 19.00% respectively.

Portfolio Pulse from Benzinga Insights

August 18, 2023 | 9:30 pm

Marijuana stocks experienced a bullish Thursday with several companies seeing significant gains. Top gainers included EVIO, Tetra Bio Pharma, GrowLife, MGC Pharmaceuticals, Heritage Cannabis Holding, Avicanna, iAnthus Capital Hldgs, TILT Holdings, InnoCan Pharma, Skye Bioscience, Willow Biosciences, OrganiGram Holdings, Village Farms Intl, WM Tech, BZAM, Leafbuyer Techs, Irwin Naturals, Canopy Gwth, CLS Holdings USA, GreenGro Technologies, Vext Science, Cronos Group, Acreage Holdings, Ispire Technology, 1933 Industries, Item 9 Labs, Delivra Health Brands, Ayr Wellness, MariMed, Akanda, and Zoned Props. However, several companies also experienced losses, including Target Group, Radient Technologies, Bright Green, Malachite Innovations, StateHouse Hldgs, Khiron Life Sciences, Cansortium, CBD Unlimited, C21 Investments, Goodness Growth Holdings, Maple Leaf Green World, Rubicon Organics, Agrify, EnWave, Acreage Holdings, Psychemedics, CNBX Pharmaceuticals, Ascend Wellness Holdings, Elixinol Wellness, Charlottes Web Holdings, Incannex Healthcare, SciSparc, SOL Glb Inv, 22nd Century Group, BioHarvest Sciences, TerrAscend, Verano Holdings, SHF Hldgs, and Livewire Ergogenics.

Portfolio Pulse from Benzinga Insights

August 17, 2023 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.